ライフサイエンスコーパス: glucose transporter 1

1 the synthesis of the ubiquitously expressed glucose transporter 1.

2 of resulting glycoconjugates, where GLUT1 is glucose transporter 1.

3 ls of vascular endothelial growth factor and glucose transporter 1.

4 ch as for VEGF, phosphoglycerate kinase, and glucose transporter-1.

5 ed upregulation of glycolytic pathway genes, glucose transporter 1-4 (Glut1-4), phosphoglycerate kina

6 Microarray experiments revealed that glucose transporters 1, 8, and 10 were expressed in MCF-

7 Immunohistochemical Ki-67 and glucose transporter 1 analysis was used to evaluate tumo

8 cell lines leads to increased expression of glucose transporter 1 and consequent increased cellular

9 imens, mRNA levels and protein expression of glucose transporter 1 and glucose transporter 3 (GLUT-1

10 Furthermore, the expression of both glucose transporter 1 and hexokinase 2, the first enzyme

11 on of glucose transporters (sodium-dependent glucose transporter-1 and glucose transporter-2) and swe

12 rom the small intestine via sodium-dependent glucose transporter-1 and glucose transporter-2, which m

13 Low serum glucose, downregulation of glucose transporter-1 and glucose-6-phosphatase mRNA, an

14 of other hypoxia-inducible genes, including glucose transporter-1 and insulin-like growth factor-bin

15 Glucose transporter-1 and Ki-67 were negative in the end

16 unohistochemical staining revealed increased glucose transporter-1 and norepinephrine transporter exp

17 tilization accompanies the downregulation of glucose transporter-1 and poly (ADP-ribose) polymerase c

18 at cells in the invasive edges expressed the glucose transporter-1 and the sodium-hydrogen exchanger-

19 Surprisingly, the expression of glucose transporters 1 and 4 and insulin receptor substr

20 lts in more abundant membrane association of glucose transporters 1 and 4, which enhances glucose upt

21 endothelial markers (von Willebrand factor, glucose transporter-1) and robust expression of tight an

22 ecreased vascular endothelial growth factor, glucose transporter 1, and erythropoietin expression.

23 encoding vascular endothelial growth factor, glucose transporter 1, and erythropoietin were up-regula

24 ith upregulation of the glucose transporter, glucose transporter 1, and glycolytic genes, hk1 and pdk

25 he expression of the HIF-1alpha-target gene, glucose transporter 1, and report that HIF-1alpha promot

26 expression of the HIF-1alpha targets VEGF-A, glucose transporter-1, and lactate dehydrogenase A.

27 The localization of uncoupling protein-1, glucose transporter-1, and norepinephrine transporter wa

28 s vascular endothelial growth factor (VEGF), glucose transporter-1, and pyruvate dehydrogenase kinase

29 E-19 cells were labeled with MCT1, MCT4, and glucose transporter-1 antibodies.

30 le proteomics approaches, we have identified glucose transporter-1 as the receptor for dematin and ad

31 ines by HIV-1 led to increased expression of glucose transporter 1, associated with increased transpo

32 Profibrotic up-regulation of glucose transporter 1 by TGF-beta involves activation of

33 Although glucose transporter 1, claudin-3, and plasmalemma vesicu

34 n CD46-costimulated T cells and identify the glucose transporter 1 encoding transcript SLC2A1 as a ta

35 Because homologues of dematin, adducin, and glucose transporter-1 exist in many non-erythroid cells,

36 y regulators in energy substrate metabolism (glucose transporter 1, glucose transporter 4, pyruvate d

37 nd expression of intestinal sodium-dependent glucose transporter-1, glucose transporter-2, and sweet

38 atients, duodenal levels of sodium-dependent glucose transporter-1, glucose transporter-2, and T1R2 t

39 ligation and puncture mice sodium-dependent glucose transporter-1, glucose transporter-2, and T1R2 t

40 man) and relative levels of sodium-dependent glucose transporter-1, glucose transporter-2, and taste

41 nterference (RNAi), to determine the role of glucose transporter 1 (GLUT-1) and GLUT-3 in L-14C-DHA t

42 searched until July 2012 by using the terms glucose transporter 1 (GLUT-1) deficiency syndrome, gluc

43 U binding studies revealed that, for HTLV-1, glucose transporter 1 (GLUT-1) functions at a postbindin

44 The observation that overexpression of glucose transporter 1 (GLUT-1) in mesangial cells could

45 ascular endothelial growth factor (VEGF) and glucose transporter 1 (Glut-1) is markedly reduced.

46 or-activated receptor gamma (PPAR-gamma) and glucose transporter 1 (GLUT-1) levels in human brain mic

47 has a bona fide candidate cellular receptor, glucose transporter 1 (glut-1), been identified.

48 s in placental homogenates and expression of glucose transporter 1 (GLUT-1), taurine transporter (TAU

49 smooth muscle actin (SMA), D2-40, CD34, and glucose transporter 1 (GLUT-1).

50 Glucose transporter-1 (Glut-1) and hexokinase II (HKII)

51 synthesized and covalently attached to anti-glucose transporter-1 (GLUT-1) antibodies via carbodiimi

52 es using adherent cell lines have shown that glucose transporter-1 (GLUT-1) can function as a recepto

53 nd to relate this to physiologic hypoxia and glucose transporter-1 (GLUT-1) expression.

54 scular endothelial growth factor (VEGF), and glucose transporter-1 (Glut-1) is mediated in part by a

55 The expression of glucose transporter-1 (Glut-1), hexokinase-1 and -2 (Hk-

56 ascular endothelial growth factor (VEGF) and glucose transporter-1 (Glut-1).

57 (DHA), enters mitochondria via facilitative glucose transporter 1 (Glut1) and accumulates mitochondr

58 hypoglycemia-induced gene expression of both glucose transporter 1 (Glut1) and inhibitor of kappa bet

59 n-responsive vesicular pool of intracellular glucose transporter 1 (GLUT1) and transferrin receptors

60 e factor 1 alpha and its downstream targets, glucose transporter 1 (GLUT1) and vascular endothelial g

61 esis was demonstrated by immunostaining with glucose transporter 1 (GLUT1) antibody, in viable vessel

62 rs-2 does regulate the surface expression of glucose transporter 1 (Glut1) as assessed by flow cytome

63 We examined whether glucose transporter 1 (GLUT1) deficiency causes common i

64 To test this hypothesis, we evaluated glucose transporter 1 (Glut1) expression and glucose upt

65 TATA sequence, whereas the promoter for the glucose transporter 1 (Glut1) gene contains a TATA eleme

66 ingle-nucleotide polymorphisms (SNPs) in the glucose transporter 1 (GLUT1) gene to the uptake of (18)

67 Glucose transporter 1 (GLUT1) immunohistochemistry was p

68 we show that expression of the facilitative glucose transporter 1 (GLUT1) is induced by TGF-beta in

69 A significant increase in the glucose transporter 1 (GLUT1) level, as well as in the g

70 tant increases in glucose import and surface glucose transporter 1 (GLUT1) levels, leading to elevate

71 The glucose transporter 1 (GLUT1) protein is underexpressed

72 tas of HF-fed animals, protein expression of glucose transporter 1 (GLUT1) was increased 5-fold, and

73 nd lipolysis (17.7%); the mRNA expression of glucose transporter 1 (GLUT1) was upregulated but glucos

74 depleted LICs by reducing the expression of glucose transporter 1 (Glut1), compromising glucose flux

75 parameters were compared with expressions of glucose transporter-1 (GLUT1) and hexokinase-2 measured

76 A structure has been proposed for glucose transporter-1 (GLUT1) based upon homology modeli

77 glycemia of maternal diabetes suppresses the glucose transporter-1 (GLUT1) facilitative glucose trans

78 r of NF-kappaB-kinase beta (IKKbeta) induced glucose transporter-1 (GLUT1) membrane trafficking in bo

79 e and paucity of its translated product, the glucose transporter-1 (Glut1) protein, disrupt brain fun

80 a proliferative arteriopathy associated with glucose transporter-1 (Glut1) up-regulation and a glycol

81 d glucose uptake through the upregulation of glucose transporter-1 (Glut1), lactate secretion and ind

82 ntial proteome analysis, we identify SLC2A1 (glucose transporter 1, GLUT1) as a downstream target of

83 lization of HIF-1alpha and an enhancement in glucose transporter-1, hexokinase-2, and monocarboxylate

84 energy, leading to increased levels of human glucose transporter 1 (hGLUT1).

85 Da protein-interacting protein 3) and GLUT1 (glucose transporter 1); (ii) secretion of pre-formed IL-

86 to meet its increased bioenergetic demands; glucose transporter-1 is up-regulated, basolateral gluco

87 s correlated by flow cytometric detection of glucose transporter 1 levels in mucosal CD4(+) T lymphoc

88 was compared with histologic scores and with glucose transporter 1 levels in mucosal immune cells by

89 ally included perturbed vascular endothelial glucose transporter-1 localization.

90 ecent structural studies suggest that GLUT1 (glucose transporter 1)-mediated sugar transport is media

91 ivity were markedly increased as a result of glucose transporter 1-mediated glucose influx that drive

92 RC2 to drive glycolysis and lipogenesis, and glucose transporter 1-mediated glucose metabolism promot

93 Furthermore, the glucose transporter-1 mRNA, which is also stabilized by

94 etabolism and increases the transcription of Glucose-transporter-1 mRNA, and of Hexokinase and Pyruva

95 2 and the cerebrovascular-selective proteins glucose transporter 1, permeability-glycoprotein, and la

96 ze, non-signet ring cell carcinoma type, and glucose transporter 1-positive expression on immunohisto

97 absorbed into intestine cells via the sodium glucose transporter 1 (SGLT-1) and glucose transporter 2

98 tration (20%) of the nonmetabolizable sodium-glucose transporter 1 (SGLT1) substrate, methyl-alpha-D-

99 hypoxia-inducible factor 1alpha (HIF1alpha), glucose transporter 1 (SLC2A1; also known as GLUT1), and

100 annexin V-depleted neutrophils, we show that glucose transporter-1 translocation is impaired in neutr

101 VHL function, we found that high basal VEGF, glucose transporter-1, urokinase-type plasminogen activa

102 or BRAF genes, we found that GLUT1, encoding glucose transporter-1, was one of three genes consistent